Discover

SGMT
Sagimet Biosciences Inc.
7.46
2 x 5.69
2 x 9.44
bid
ask
-
0.27
3.49%
2 @ 07:14 AM
7.55 +0.09 (1.21%)
Ytd26.01%
1y-7.10%
7.31
day range
7.95
4.50
52 week range
11.41
Open7.75Prev Close7.73Low7.31High7.95Mkt Cap460.67M
Vol1.25MAvg Vol1.80MEPS-1.35P/EN/AForward P/E-1.40
BetaN/AShort Ratio1.37Inst. Own66.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg7.11200-d Avg6.551yr Est29.14

SGMT News

benzinga.com
Sagimet Biosciences Added To Broad-Market Russell 3000 Index And Small-Cap Russell 2000 Index

Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes
globenewswire.com
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

SAN MATEO, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clin

Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

US stock futures up, Nasdaq futures 1% higher. Legend Biotech (LEGN) priced 7.7 million ADSs at $29.

benzinga.com
UK's MHRA Says Resmetirom (Rezdiffra) Authorized To Treat Metabolic Dysfunction-Associated Steatohep

https://www.gov.uk/government/news/resmetirom-rezdiffra-authorised-to-treat-metabolic-dysfunction-as

benzinga.com
Sagimet Biosciences Presents Two Posters At EASL 2026; Denifanstat/Resmetirom Phase 1 Data Selected

Phase 1 clinical data poster selected as a Best of EASL 2026 presentationCombination of denifanstat

benzinga.com
Citizens Maintains Market Outperform on Sagimet Biosciences, Lowers Price Target to $12

Citizens analyst Jonathan Wolleben maintains Sagimet Biosciences (NASDAQ:SGMT) with a Market Outp

benzinga.com
Sagimet Biosciences Q1 EPS $(0.33) Beats $(0.36) Estimate

Sagimet Biosciences (NASDAQ:SGMT) reported quarterly losses of $(0.33) per share which beat the anal

benzinga.com
Canaccord Genuity Maintains Buy on Sagimet Biosciences, Raises Price Target to $49

Canaccord Genuity analyst Edward Nash maintains Sagimet Biosciences (NASDAQ:SGMT) with a Buy and

benzinga.com
Guggenheim Maintains Buy on Sagimet Biosciences, Lowers Price Target to $25

Guggenheim analyst Seamus Fernandez maintains Sagimet Biosciences (NASDAQ:SGMT) with a Buy and lo

Why Is Sagimet Biosciences Stock Trading Higher On Monday?
benzinga.com
Why Is Sagimet Biosciences Stock Trading Higher On Monday?

Sagimet shares surge as Phase 3 acne trial plans and $175M offering fund pipeline through 2028, with

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
Sagimet Biosciences Prices Underwritten Offering Of 29,166,700 Shares Of Series A Common Stock At $6

Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel

benzinga.com
Sagimet Biosciences Plans To Initiate Phase 3 Clinical Trial Of Denifanstat In Moderate To Severe Ac

Phase 3 clinical trial of denifanstat in moderate to severe acne patients for the U.S. planned to in

benzinga.com
Sagimet to Share Mid-Stage Liver Disease Drug Data at Medical Conference

Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel

benzinga.com
HC Wainwright & Co. Reiterates Buy on Sagimet Biosciences, Maintains $29 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Sagimet Biosciences (NASDAQ:SGMT) with

benzinga.com
Sagimet Biosciences Q4 EPS $(0.29) Beats $(0.48) Estimate

Sagimet Biosciences (NASDAQ:SGMT) reported quarterly losses of $(0.29) per share which beat the anal

benzinga.com
Guggenheim Initiates Coverage On Sagimet Biosciences with Buy Rating, Announces Price Target of $27

Guggenheim analyst Seamus Fernandez initiates coverage on Sagimet Biosciences (NASDAQ:SGMT) with

benzinga.com
HC Wainwright & Co. Reiterates Buy on Sagimet Biosciences, Maintains $29 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Sagimet Biosciences (NASDAQ:SGMT) with

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com
Ascletis Pharma Releases Topline Data From Phase 3 Open-Label Study Of Denifanstat (ASC40), Licensed

Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable

benzinga.com
Barclays Initiates Coverage On Sagimet Biosciences with Equal-Weight Rating, Announces Price Target

Barclays analyst Eliana Merle initiates coverage on Sagimet Biosciences (NASDAQ:SGMT) with a Equa

benzinga.com
Sagimet Reports MASH Combo Data, Eyes Phase 2 for Liver Treatment

Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel

benzinga.com
Sagimet Biosciences Announced A License Agreement With A Subsidiary Of Teva Pharmaceutical

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom activ

benzinga.com
Sagimet's License Partner Ascletis Pharma Issues Statement That China's National Medical Products Ad

Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

benzinga.com
This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

benzinga.com
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday'

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acqu

benzinga.com
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Ses

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbe

benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid

Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company a

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 369 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 386 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  Wednesday's session saw 150 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 210 companies reached new 52-week lows.